Veru Inc.

NasdaqCM:VERU Stock Report

Market Cap: US$108.0m

Veru Management

Management criteria checks 3/4

Veru's CEO is Mitch Steiner, appointed in Oct 2016, has a tenure of 8.25 years. total yearly compensation is $4.71M, comprised of 18.4% salary and 81.6% bonuses, including company stock and options. directly owns 4.84% of the company’s shares, worth $5.23M. The average tenure of the management team and the board of directors is 6.3 years and 4 years respectively.

Key information

Mitch Steiner

Chief executive officer

US$4.7m

Total compensation

CEO salary percentage18.4%
CEO tenure8.3yrs
CEO ownership4.8%
Management average tenure6.3yrs
Board average tenure4yrs

Recent management updates

Recent updates

Is Veru (NASDAQ:VERU) Using Debt In A Risky Way?

Dec 18
Is Veru (NASDAQ:VERU) Using Debt In A Risky Way?

Is Veru (NASDAQ:VERU) A Risky Investment?

Aug 07
Is Veru (NASDAQ:VERU) A Risky Investment?

What Veru Inc.'s (NASDAQ:VERU) 28% Share Price Gain Is Not Telling You

Jul 17
What Veru Inc.'s (NASDAQ:VERU) 28% Share Price Gain Is Not Telling You

Veru Inc.'s (NASDAQ:VERU) 35% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

May 31
Veru Inc.'s (NASDAQ:VERU) 35% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 52%

Jan 09
The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 52%

Revenue Downgrade: Here's What Analysts Forecast For Veru Inc. (NASDAQ:VERU)

Aug 16
Revenue Downgrade: Here's What Analysts Forecast For Veru Inc. (NASDAQ:VERU)

Veru Inc.'s (NASDAQ:VERU) Stock Retreats 38% But Revenues Haven't Escaped The Attention Of Investors

Apr 17
Veru Inc.'s (NASDAQ:VERU) Stock Retreats 38% But Revenues Haven't Escaped The Attention Of Investors

Veru Inc.'s (NASDAQ:VERU) Intrinsic Value Is Potentially 99% Above Its Share Price

Feb 14
Veru Inc.'s (NASDAQ:VERU) Intrinsic Value Is Potentially 99% Above Its Share Price

Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry?

Jan 13
Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry?

Analysts Just Shaved Their Veru Inc. (NASDAQ:VERU) Forecasts Dramatically

Nov 13
Analysts Just Shaved Their Veru Inc. (NASDAQ:VERU) Forecasts Dramatically

Veru Inc.: Safer Bet Is To Wait For The AdComm Verdict

Oct 17

Is Veru (NASDAQ:VERU) Weighed On By Its Debt Load?

Sep 26
Is Veru (NASDAQ:VERU) Weighed On By Its Debt Load?

Veru FDA AdCom meeting for COVID-19 therapy postponed

Sep 19

Veru: A Good Combination Of A Stable Business And Growth Opportunities

Sep 13

Veru surges 11% as FDA sets AdCom meeting to review COVID-19 therapy

Sep 07

CEO Compensation Analysis

How has Mitch Steiner's remuneration changed compared to Veru's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$38m

Jun 30 2024n/an/a

-US$37m

Mar 31 2024n/an/a

-US$39m

Dec 31 2023n/an/a

-US$63m

Sep 30 2023US$5mUS$866k

-US$93m

Jun 30 2023n/an/a

-US$126m

Mar 31 2023n/an/a

-US$136m

Dec 31 2022n/an/a

-US$116m

Sep 30 2022US$6mUS$761k

-US$84m

Jun 30 2022n/an/a

-US$47m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021n/an/a

-US$16m

Sep 30 2021US$2mUS$618k

US$7m

Jun 30 2021n/an/a

-US$144k

Mar 31 2021n/an/a

-US$476k

Dec 31 2020n/an/a

US$2m

Sep 30 2020US$1mUS$502k

-US$19m

Jun 30 2020n/an/a

-US$10m

Mar 31 2020n/an/a

-US$10m

Dec 31 2019n/an/a

-US$13m

Sep 30 2019US$800kUS$392k

-US$12m

Jun 30 2019n/an/a

-US$17m

Mar 31 2019n/an/a

-US$22m

Dec 31 2018n/an/a

-US$22m

Sep 30 2018US$740kUS$383k

-US$24m

Compensation vs Market: Mitch's total compensation ($USD4.71M) is above average for companies of similar size in the US market ($USD642.68K).

Compensation vs Earnings: Mitch's compensation has been consistent with company performance over the past year.

CEO

Mitch Steiner (63 yo)

8.3yrs

Tenure

US$4,714,041

Compensation

Dr. Mitchell S. Steiner, also known as Mitch, M.D., F.A.C.S, has been the Chief Executive Officer, President and Director at Veru Inc. (formerly known as The Female Health Company) since October 31, 2016 &...

Leadership Team

NamePositionTenureCompensationOwnership
Mitchell Steiner
Chairman8.3yrsUS$4.71m4.84%
$ 5.2m
Harry Fisch
Vice Chairman & Chief Corporate Officer8.3yrsno data5.47%
$ 5.9m
Michele Greco
CFO & Chief Administrative Officer7.1yrsUS$1.55m0.066%
$ 70.9k
K. Barnette
Chief Scientific Officer6.3yrsUS$1.69m0.0034%
$ 3.7k
Samuel Fisch
Executive Director of Investor Relations & Corporate Communications5.8yrsno datano data
Michael Purvis
Executive VP3.8yrsno datano data
Kevin Gilbert
Executive Vice President of Corporate Development8yrsno datano data
Martin Tayler
Executive Vice President of FC2 Global Operationsno dataUS$193.01kno data
Philip Greenberg
Executive VP & Deputy General Counsel4yrsno datano data
Domingo Rodriguez
Executive Vice President of Global Clinical Operations6.8yrsno datano data
Gary Bird
Executive Vice President of Quality & Regulatory Affairs5.9yrsno datano data
Sergi Trilla
Chief Business Officer3yrsno datano data

6.3yrs

Average Tenure

62.5yo

Average Age

Experienced Management: VERU's management team is seasoned and experienced (6.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mitchell Steiner
Chairman8.3yrsUS$4.71m4.84%
$ 5.2m
Harry Fisch
Vice Chairman & Chief Corporate Officer8.3yrsno data5.47%
$ 5.9m
Louis Aronne
Chief Medical Advisor & Member of the Scientific Advisoryless than a yearno datano data
Andrew Love
Board Observer8.3yrsno datano data
Adrian Dobs
Member of Scientific Advisory Boardless than a yearno datano data
William Evans
Member of Scientific Advisory Boardless than a yearno datano data
Michael Rankowitz
Independent Director6.8yrsUS$875.93k0.068%
$ 73.7k
Xiaoqin Lu
Independent Director3.7yrsUS$835.75k0.0067%
$ 7.2k
Caroline Apovian
Member of Scientific Advisory Boardless than a yearno datano data
Mario Eisenberger
Independent Director8.3yrsUS$795.57k0%
$ 0
Grace Hyun
Independent Director4.4yrsUS$755.39k0.010%
$ 10.9k
Shalender Bhasin
Member of Scientific Advisory Boardless than a yearno datano data

4.0yrs

Average Tenure

65.5yo

Average Age

Experienced Board: VERU's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 14:44
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Veru Inc. is covered by 11 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William WoodB. Riley Securities, Inc.
Brandon FolkesCantor Fitzgerald & Co.
Yi ChenH.C. Wainwright & Co.